Drug intelligence / Profile preview

Vectra 3D

Development stage
Unknown
Lead developer
Ceva Animal Health
Modality
Small Molecules
Administration
Topical
01

Overview

Vectra 3D is a topical veterinary combination drug developed by Ceva Animal Health for the treatment and prevention of parasitic infections in dogs. The formulation contains three active ingredients that work synergistically to provide broad-spectrum protection: dinotefuran, a fast-acting neonicotinoid insecticide that targets nicotinic acetylcholine receptors; permethrin, a broad-spectrum pyrethroid that acts on sodium channels to repel and kill parasites; and pyriproxyfen, an insect growth regulator that targets juvenile hormone receptors to prevent flea eggs and larvae from maturing. Applied as a monthly spot-on treatment, Vectra 3D kills parasites through contact, meaning they do not need to bite the animal to be affected. It is effective against fleas, ticks, mosquitoes, lice, mites, and sand flies, with sustained efficacy lasting at least 30 days after a single application.

Brand names
Vectra 3DVectra3DVectra-3D
Other names
dinotefuran + pyriproxyfen + permethrin
02

Targets

Nicotinic Acetylcholine ReceptorNaV (Voltage-gated sodium channels)MET (Mesenchymal-epithelial transition factor receptor)

Beyond the preview

Go deeper on Vectra 3D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vectra 3D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call